204 research outputs found

    Analisis Risiko dan Keamanan Informasi pada Sebuah Perusahaan System Integrator Menggunakan Metode Octave Allegro

    Get PDF
    PT. XYZ sebagai salah satu perusahaan yang bergerak di bidang System Integrator telah menggunakan teknologi informasi dalam menjalankan aktivitas bisnisnya. PT. XYZ merupakan penyedia solusi teknologi informasi dan komunikasi di Indonesia yang menyediakan layanan pengadaan & implementasi infrastruktur TI serta layanan keamanan teknologi informasi. Aset informasi yang dimiliki PT. XYZ adalah aset informasi internal perusahaan termasuk aset informasi terkait customer. Sehingga dibutuhkan manajemen sistem informasi yang handal dan mendukung prinsip keamanan informasi yaitu kerahasiaan, keutuhan, dan ketersediaan.  Pada tahun 2019 PT. XYZ mengalami insiden serangan ransomware yang mengakibatkan data – data proyek dan data customer ter-enkripsi. Hal ini berdampak terhadap produktivitas & reputasi perusahaan karena kehilangan aset informasi yang diperlukan. Dengan demikian diperlukan penilaian risiko untuk dapat menentukan  strategi mitigasi risiko sebagai langkah manajemen risiko dalam mengatasi dan meminimalisir dampak permasalahan terkait keamanan informasi. Metode penilaian risiko yang digunakan dalam penelitian ini adalah Metode OCTAVE Allegro yang menggunakan 8 tahapan untuk dapat mengidentifikasi, menganalisa dan menentukan pendekatan mitigasi risiko. Penelitian ini mengidentifikasi aset informasi perusahaan berdasarkan pengumpulan data melalui wawancara narasumber PT.XYZ dan observasi. Dengan metode OCTAVE Allegro ditemukan 6 area of concern yang berpotensi menjadi risiko keamanan informasi dimana aset informasi teridentifikasi memiliki skor risiko relative ≥ 30 yang termasuk tinggi dalam rentang skor  matriks risiko.  Dengan demikian, diperlukan penilaian risiko untuk dapat menentukan strategi mitigasi risiko

    Basis-independent methods for the two-Higgs-doublet model II. The significance of tan(beta)

    Full text link
    In the most general two-Higgs-doublet model (2HDM), there is no distinction between the two complex hypercharge-one SU(2) doublet scalar fields, Phi_a (a=1,2). Thus, any two orthonormal linear combinations of these two fields can serve as a basis for the Lagrangian. All physical observables of the model must therefore be basis-independent. For example, tan(beta)=/ is basis-dependent and thus cannot be a physical parameter of the model. In this paper, we provide a basis-independent treatment of the Higgs sector with particular attention to the neutral Higgs boson mass-eigenstates, which generically are not eigenstates of CP. We then demonstrate that all physical Higgs couplings are indeed independent of tan(beta). In specialized versions of the 2HDM, tan(beta) can be promoted to a physical parameter of the Higgs-fermion interactions. In the most general 2HDM, the Higgs-fermion couplings can be expressed in terms of a number of physical "tan(beta)--like" parameters that are manifestly basis-independent. The minimal supersymmetric extension of the Standard Model provides a simple framework for exhibiting such effects.Comment: 56 pages, 5 tables, with Eq. (65) corrected (erratum to appear in Physical Review D

    How a typical West African day in the future-climate compares with current-climate conditions in a convection-permitting and parameterised convection climate model

    Get PDF
    Current-climate precipitation and temperature extremes have been identified by decision makers in West Africa as among the more impactful weather events causing lasting socioeconomic damage. In this article, we use a plausible future-climate scenario (RCP8.5) for the end of the twenty-first century to explore the relative commonness of such extremes under global warming. The analysis presented considers what a typical day in the future climate will feel like relative to current extrema. Across much of West Africa, we see that the typical future-climate day has maximum and minimum temperatures greater than 99.5% of currently experienced values. This finding exists for most months but is particularly pronounced during the Boreal spring and summer. The typical future precipitation event has a daily rainfall rate greater than 95% of current storms. These findings exist in both a future scenario model run with and without parameterised convection, and for many of the Coupled Model Inter-comparison Project version 5 ensemble members. Additionally, agronomic monsoon onset is projected to occur later and have greater inter-annual variability in the future. Our findings suggest far more extreme conditions in future climate over West Africa. The projected changes in temperature and precipitation could have serious socioeconomic implications, stressing the need for effective mitigation given the potential lack of adaptation pathways available to decision makers

    An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours.

    Get PDF
    BACKGROUND: Dose-escalation of epertinib (S-222611), a new potent oral EGFR/HER2 inhibitor, has established a recommended daily dose of 800 mg in patients with solid tumours. In this study, we have recruited a larger number of patients to assess further the safety, tolerability, pharmacokinetics (PKs) and antitumour activity. PATIENTS AND METHODS: Patients with solid tumours expressing EGFR or HER2 received a single dose of epertinib at 800 mg on Day 1 to assess PK over 7 days, followed by continuous once-daily dosing from Day 8. RESULTS: We treated 76 patients with breast (n = 27), upper gastrointestinal (GI; n = 30), head and neck (n = 12) or renal cancers (n = 7). Epertinib was well-tolerated with mostly grade I and II adverse events (AEs). The most frequent AE was diarrhoea, which was generally manageable with loperamide. The objective response rate (ORR) in patients with heavily pretreated breast and upper GI cancers was 16.0% (4 PRs) and 8.3% (1CR, 1PR), respectively. All six responding patients had HER2-positive tumours; the ORR for HER2-positive breast and upper GI cancer populations was 19.0% and 20.0%. Partial response in the brain disease of one breast cancer patient lasted 7.5 months. CONCLUSION: Once-daily dosing of epertinib at 800 mg was well-tolerated and demonstrated promising antitumour activity in patients with heavily pretreated HER2-positive breast and upper GI cancer, including those with brain metastases. EUDRACT NUMBER: 2009-017817-31

    Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy

    Get PDF
    Aims Cardiovascular magnetic resonance (CMR) has improved diagnostic and management strategies in hypertrophic cardiomyopathy (HCM) by expanding our appreciation for the diverse phenotypic expression. We sought to characterize the prevalence and clinical significance of a recently identified accessory left ventricular (LV) muscle bundle extending from the apex to the basal septum or anterior wall (i.e. apical-basal). Methods and results CMR was performed in 230 genotyped HCM patients (48 ± 15 years, 69% male), 30 genotype-positive/phenotype-negative (G+/P−) family members (32 ± 15 years, 30% male), and 126 controls. Left ventricular apical-basal muscle bundle was identified in 145 of 230 (63%) HCM patients, 18 of 30 (60%) G+/P− family members, and 12 of 126 (10%) controls (G+/P− vs. controls; P < 0.01). In HCM patients, the prevalence of an apical-basal muscle bundle was similar among those with disease-causing sarcomere mutations compared with patients without mutation (64 vs. 62%; P = 0.88). The presence of an LV apical-basal muscle bundle was not associated with LV outflow tract obstruction (P = 0.61). In follow-up, 33 patients underwent surgical myectomy of whom 22 (67%) were identified to have an accessory LV apical-basal muscle bundle, which was resected in all patients. Conclusion Apical-basal muscle bundles are a unique myocardial structure commonly present in HCM patients as well as in G+/P− family members and may represent an additional morphologic marker for HCM diagnosis in genotype-positive statu

    Graph Regionalization with Clustering and Partitioning: an Application for Daily Commuting Flows in Albania

    Get PDF
    The paper presents an original application of the recently proposed spatial data mining method named GraphRECAP on daily commuting flows using 2011 Albanian census data. Its aim is to identify several clusters of Albanian municipalities/communes; propose a classification of the Albanian territory based on daily commuting flows among municipalities/communes. Starting from 373 local units, we first applied a spatial clustering technique without imposing any constraining strategy. Based on the input variables, we obtained 16 clusters. In the second step of our analysis, we impose a set of constraining parameters to identify intermediate areas between the local level (municipality/commune) and the national one. We have defined 12 derived regions (same number as the actual Albanian prefectures but with different geographies). These derived regions are quite different from the traditional ones in terms of both geographical dimensions and boundarie

    The expanding functional roles and signaling mechanisms of adhesion G protein–coupled receptors

    Get PDF
    The adhesion class of G protein–coupled receptors (GPCRs) is the second largest family of GPCRs (33 members in humans). Adhesion GPCRs (aGPCRs) are defined by a large extracellular N‐terminal region that is linked to a C‐terminal seven transmembrane (7TM) domain via a GPCR‐autoproteolysis inducing (GAIN) domain containing a GPCR proteolytic site (GPS). Most aGPCRs undergo autoproteolysis at the GPS motif, but the cleaved fragments stay closely associated, with the N‐terminal fragment (NTF) bound to the 7TM of the C‐terminal fragment (CTF). The NTFs of most aGPCRs contain domains known to be involved in cell–cell adhesion, while the CTFs are involved in classical G protein signaling, as well as other intracellular signaling. In this workshop report, we review the most recent findings on the biology, signaling mechanisms, and physiological functions of aGPCRs

    Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020 : the right to sight : an analysis for the Global Burden of Disease Study

    Get PDF
    Background: Many causes of vision impairment can be prevented or treated. With an ageing global population, the demands for eye health services are increasing. We estimated the prevalence and relative contribution of avoidable causes of blindness and vision impairment globally from 1990 to 2020. We aimed to compare the results with the World Health Assembly Global Action Plan (WHA GAP) target of a 25% global reduction from 2010 to 2019 in avoidable vision impairment, defined as cataract and undercorrected refractive error.Methods: We did a systematic review and meta-analysis of population-based surveys of eye disease from January, 1980, to October, 2018. We fitted hierarchical models to estimate prevalence (with 95% uncertainty intervals [UIs]) of moderate and severe vision impairment (MSVI; presenting visual acuity from <6/18 to 3/60) and blindness (<3/60 or less than 10° visual field around central fixation) by cause, age, region, and year. Because of data sparsity at younger ages, our analysis focused on adults aged 50 years and older.Findings: Global crude prevalence of avoidable vision impairment and blindness in adults aged 50 years and older did not change between 2010 and 2019 (percentage change −0·2% [95% UI −1·5 to 1·0]; 2019 prevalence 9·58 cases per 1000 people [95% IU 8·51 to 10·8], 2010 prevalence 96·0 cases per 1000 people [86·0 to 107·0]). Age-standardised prevalence of avoidable blindness decreased by −15·4% [–16·8 to −14·3], while avoidable MSVI showed no change (0·5% [–0·8 to 1·6]). However, the number of cases increased for both avoidable blindness (10·8% [8·9 to 12·4]) and MSVI (31·5% [30·0 to 33·1]). The leading global causes of blindness in those aged 50 years and older in 2020 were cataract (15·2 million cases [9% IU 12·7–18·0]), followed by glaucoma (3·6 million cases [2·8–4·4]), undercorrected refractive error (2·3 million cases [1·8–2·8]), age-related macular degeneration (1·8 million cases [1·3–2·4]), and diabetic retinopathy (0·86 million cases [0·59–1·23]). Leading causes of MSVI were undercorrected refractive error (86·1 million cases [74·2–101·0]) and cataract (78·8 million cases [67·2–91·4]).Interpretation: Results suggest eye care services contributed to the observed reduction of age-standardised rates of avoidable blindness but not of MSVI, and that the target in an ageing global population was not reached
    corecore